Selecting the right primary container for an injectable drug or passing a device design verification test are crucial steps in the product development process. So, the pressure is on to get it right the first time. Stevanato to Group’s state-of-the-art Technology Excellence Centers can offer analytical and device testing services to support customers all the way, from early-stage to launched combination product
Chemical interactions between drug and container could lead to glass delamination, high extrusion forces and other container failures. Allowing Stevanato Group to de-risk the container selection can ensure commercial success.
Stevanato Group’s Technology Excellence Centers are state-of-the-art facilities located at the headquarters in Italy and in the biotech hub of Boston, USA. They cover a range of specialized fields including container closure systems and drug-delivery devices. A team of more than forty highly skilled professionals, comprising scientists, engineers, pharmaceutical chemists and biotechnologists are committed to offering their know-how and enthusiasm to turn a project into an achievement.